Combined lysophosphatidic acid/platelet-derived growth factor signaling triggers glioma cell migration in a tenascin-C microenvironment
Related Experiment Video
Updated: Jul 2, 2026

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion
Published on: October 20, 2016
Katrin Lange1, Martial Kammerer, Falk Saupe
1Institute of Biochemistry and Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland.
Abstract:
The antiadhesive extracellular matrix molecule tenascin-C abrogates cell spreading on fibronectin through competitive inhibition of syndecan-4, thereby preventing focal adhesion kinase (FAK) activation and triggering enhanced proteolytic degradation of both RhoA and tropomyosin 1 (TM1). Here, we show that simultaneous signaling by lysophosphatidic acid (LPA) and platelet-derived growth factor (PDGF) initiates glioma cell spreading and migration through syndecan-4-independent activation of paxillin and FAK and by stabilizing expression of RhoA, TM1, TM2, and TM3. By using gene silencing methods, we show that paxillin, TM1, TM2, and TM3 are essential for LPA/PDGF-induced cell spreading on a fibronectin/tenascin-C (FN/TN) substratum. LPA/PDGF-induced cell spreading and migration on FN/TN depends on phosphatidylinositol 3-kinase, RhoKinase, and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 but is independent of phospholipase C and Jun kinase. RNA microarray data reveal expression of tenascin-C, PDGFs, LPA, and the respective receptors in several types of cancer, suggesting that the TN/LPA/PDGF axis exists in malignant tumors. These findings may in turn be relevant for diagnostic or therapeutic applications targeting cancer.
Insights
Lysophosphatidic acid (LPA) and platelet-derived growth factor (PDGF) promote glioma cell spreading and migration via a novel pathway. This tenascin-C (TN) and fibronectin (FN) interaction offers potential cancer diagnostic and therapeutic targets.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Tenascin-C (TN) inhibits cell spreading by blocking syndecan-4, preventing focal adhesion kinase (FAK) activation and promoting protein degradation.
- Understanding alternative pathways for cell migration is crucial for cancer research.
Purpose of the Study:
- To investigate the mechanisms by which lysophosphatidic acid (LPA) and platelet-derived growth factor (PDGF) induce glioma cell spreading and migration.
- To identify key molecular players and signaling pathways involved in this process on a fibronectin/tenascin-C (FN/TN) substratum.
Main Methods:
- Gene silencing techniques were employed to assess the necessity of specific proteins (paxillin, tropomyosin 1, 2, and 3).
- Analysis of signaling pathway involvement, including phosphatidylinositol 3-kinase, RhoKinase, and MAPK/ERK kinase 1/2.
- RNA microarray analysis to identify expression patterns of TN, PDGF, LPA, and their receptors in various cancers.
Main Results:
- Simultaneous LPA and PDGF signaling triggers glioma cell spreading and migration independently of syndecan-4.
- This process involves the activation of paxillin and FAK, and stabilization of RhoA, TM1, TM2, and TM3.
- Paxillin, TM1, TM2, and TM3 were found to be essential for LPA/PDGF-induced cell spreading on FN/TN.
- The pathway is dependent on PI3K, RhoKinase, and MAPK/ERK kinase 1/2, but not PLC or JNK.
Conclusions:
- A novel TN/LPA/PDGF signaling axis promotes glioma cell migration, distinct from the previously known TN/syndecan-4 pathway.
- This axis is active in malignant tumors, suggesting potential diagnostic and therapeutic applications.
- Targeting this pathway could offer new strategies for cancer treatment.
Related Concept Videos
Mitogens and the Cell Cycle
Intracellular Signaling Affects Focal Adhesions
Some...
Cell Polarization by Rho Proteins
TGF - β Signaling Pathway
The Tumor Microenvironment
Cancer Cell Migration through Invadopodia

